Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Tianeptine Versus Escitalopram for the Treatment of Depression and Cognitive Impairment in Patients With Major Depressive Disorder: A Randomized, Multicenter, Open-label Study

NCT01309776 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01309776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01309776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Tianeptine Versus Escitalopram for the Treatment of Depression and Cognitive Impairment in Patients With Major Depressive Disorder: A Randomized, Multicenter, Open-label Study
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2011
Completion date
September 30, 2012
Enrollment
164 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder